(Q38882145)

7 September 2017

title

Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda (English)

1 reference

7 September 2017

0 references

0 references

0 references

5

Grant Dorsey

1 reference

7 September 2017

4

Moses R Kamya

1 reference

7 September 2017

6

Philip J Rosenthal

1 reference

7 September 2017

1

Sarah G Staedke

1 reference

7 September 2017

Hakim Sendagire

2

1 reference

7 September 2017

Steven Lamola

series ordinal

3

1 reference

7 September 2017

language of work or name

1 reference

1 May 2004

1 reference

Tropical Medicine and International Health

7 September 2017

published in

1 reference

7 September 2017

volume

9

1 reference

7 September 2017

issue

5

1 reference

7 September 2017

page(s)

624-629

1 reference

Making malaria-treatment policy in the face of drug resistance

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2004.01239.X

Antimalarial drugs clear resistant parasites from partially immune hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2004.01239.X

Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2004.01239.X

Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2004.01239.X

The evolution of drug-resistant malaria: the role of drug elimination half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2004.01239.X

The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2004.01239.X

Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2004.01239.X

Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2004.01239.X

Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2004.01239.X

Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2004.01239.X

Epidemiology of drug resistance in malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2004.01239.X

The assessment of antimalarial drug efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2004.01239.X

Averting a malaria disaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2004.01239.X

Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2004.01239.X

10.1111/J.1365-3156.2004.01239.X

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference